Inducible Production of Nitric Oxide in Osteoblast-like Cells and in Fetal Mouse Bone Explants is Associated with Suppression of Osteoclastic Bone Resorption

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1994 Apr 1

PMID 8163651

Citations 43

Authors

C W Lowik

P H Nibbering

M Van de Ruit

S E Papapoulos

Affiliations

Soon will be listed here.

Abstract

Nitric oxide (NO) has been suggested to be involved in the regulation of osteoclast activity. Since osteoblasts, through the release of various factors, are the main regulators of osteoclastic resorption, first we have investigated whether osteoblast-like cells and fetal mouse long bone explants are able to produce NO. Second, we have assessed the effect of NO on osteoclastic resorption in whole bone cultures. In this study we show that primary rat osteoblast-like cells as well as the clonal rat osteoblast-like cell line UMR-106, stimulated with IFN-gamma together with TNF-alpha and LPS, produce NO, measured as nitrite production. IL-1 alpha enhanced while TGF-beta 2 inhibited TNF-alpha + IFN-gamma + LPS-stimulated NO production in UMR-106 cells dose dependently. Both the cytokines, however, had no effect when given alone. The competitive inhibitor of NO production, NG-monomethyl-arginine (L-NMMA), and cycloheximide abolished the increase in nitrite production induced by TNF-alpha + IFN-gamma + LPS, while hydrocortisone had no effect, as previously reported for chondrocytes. Calciotropic hormones had either no effect [1,25(OH)2D3] or had a small inhibitory effect (parathyroid hormone) on stimulated NO production. Furthermore, we found that in cultured fetal mouse long bone explants the combination of TNF-alpha + IFN-gamma + LPS as well as the NO donor sodium nitroprusside could inhibit osteoclastic resorption, measured as 45Ca release. The inhibition of resorption was prevented by concurrent administration of L-NMMA. Histological evaluation revealed that the TNF-alpha + IFN-gamma + LPS-induced inhibition of 45Ca release was associated with a decrease in the number of tartrate-resistant acid phosphatase-positive osteoclasts. We propose that the NO production by osteogenic cells (osteoblasts and chondrocytes) may represent an important regulatory mechanism of osteoclastic activity especially under pathological conditions characterized by release of bone-resorbing inflammatory cytokines.

Citing Articles

Identification of genetic association between mitochondrial dysfunction and knee osteoarthritis through integrating multi-omics: a summary data-based Mendelian randomization study.

Xie J, Ma R, Xu X, Yang M, Yu H, Wan X Clin Rheumatol. 2024; 43(11):3487-3496.

PMID: 39259428 PMC: 11489259. DOI: 10.1007/s10067-024-07136-7.

Electrospun Poly-L-Lactic Acid Scaffolds Surface-Modified via Reactive Magnetron Sputtering Using Different Mixing Ratios of Nitrogen and Xenon.

Maryin P, Tran T, Frolova A, Buldakov M, Choinzonov E, Kozelskaya A Polymers (Basel). 2023; 15(13).

PMID: 37447614 PMC: 10347186. DOI: 10.3390/polym15132969.

Serum nitric oxide concentration in generalized chronic and aggressive periodontitis in the Mexican population is not related to the severity of the disease.

Fuentes-Lerma M, Zamora-Perez A, Robles-Gomez C, Guerrero-Velazquez C, Peregrina-Sandoval J, Gutierrez-Angulo M Biomedica. 2023; 43(1):61-68.

PMID: 37167463 PMC: 10476647. DOI: 10.7705/biomedica.6690.

Connection between Osteoarthritis and Nitric Oxide: From Pathophysiology to Therapeutic Target.

Jiang H, Ji P, Shang X, Zhou Y Molecules. 2023; 28(4).

PMID: 36838671 PMC: 9959782. DOI: 10.3390/molecules28041683.

Local delivery of gaseous signaling molecules for orthopedic disease therapy.

Sun J, Wang W, Hu X, Zhang X, Zhu C, Hu J J Nanobiotechnology. 2023; 21(1):58.

PMID: 36810201 PMC: 9942085. DOI: 10.1186/s12951-023-01813-6.

References

Rodan G, Martin T . Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int. 1981; 33(4):349-51. DOI: 10.1007/BF02409454. View

Palmer R, Hickery M, Charles I, Moncada S, Bayliss M . Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun. 1993; 193(1):398-405. DOI: 10.1006/bbrc.1993.1637. View

Scheven B, Wassenaar A, Nijweide P . Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitro. Anat Rec. 1986; 214(4):418-23. DOI: 10.1002/ar.1092140413. View

Stolzenburg T, Binz H, Fontana A, Felder M, WAGENHAEUSER F . Impaired mitogen-induced interferon-gamma production in rheumatoid arthritis and related diseases. Scand J Immunol. 1988; 27(1):73-81. DOI: 10.1111/j.1365-3083.1988.tb02324.x. View

Gowen M, Nedwin G, Mundy G . Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J Bone Miner Res. 1986; 1(5):469-74. DOI: 10.1002/jbmr.5650010511. View

Stuehr D, Nathan C . Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 1989; 169(5):1543-55. PMC: 2189318. DOI: 10.1084/jem.169.5.1543. View

Ding A, Nathan C, Graycar J, Derynck R, Stuehr D, Srimal S . Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol. 1990; 145(3):940-4. View

Di Rosa M, Radomski M, Carnuccio R, Moncada S . Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun. 1990; 172(3):1246-52. DOI: 10.1016/0006-291x(90)91583-e. View

Werner-Felmayer G, Werner E, Fuchs D, Hausen A, Reibnegger G, Wachter H . Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med. 1990; 172(6):1599-607. PMC: 2188745. DOI: 10.1084/jem.172.6.1599. View

10.

MacIntyre I, Zaidi M, Alam A, Datta H, Moonga B, Lidbury P . Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci U S A. 1991; 88(7):2936-40. PMC: 51355. DOI: 10.1073/pnas.88.7.2936. View

11.

Nathan C, Hibbs Jr J . Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991; 3(1):65-70. DOI: 10.1016/0952-7915(91)90079-g. View

12.

Bredt D, Hwang P, Glatt C, Lowenstein C, Reed R, Snyder S . Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991; 351(6329):714-8. DOI: 10.1038/351714a0. View

13.

Moncada S, Palmer R . Inhibition of the induction of nitric oxide synthase by glucocorticoids: yet another explanation for their anti-inflammatory effects?. Trends Pharmacol Sci. 1991; 12(4):130-1. DOI: 10.1016/0165-6147(91)90528-z. View

14.

Moncada S, Palmer R, Higgs E . Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43(2):109-42. View

15.

Stadler J, Stefanovic-Racic M, Billiar T, Curran R, McIntyre L, Georgescu H . Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol. 1991; 147(11):3915-20. View

16.

Xie Q, Cho H, Calaycay J, Mumford R, Swiderek K, Lee T . Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992; 256(5054):225-8. DOI: 10.1126/science.1373522. View

17.

Nussler A, Di Silvio M, Billiar T, Hoffman R, Geller D, Selby R . Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med. 1992; 176(1):261-4. PMC: 2119287. DOI: 10.1084/jem.176.1.261. View

18.

Lamas S, Marsden P, Li G, Tempst P, Michel T . Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992; 89(14):6348-52. PMC: 49498. DOI: 10.1073/pnas.89.14.6348. View

19.

Lowenstein C, Snyder S . Nitric oxide, a novel biologic messenger. Cell. 1992; 70(5):705-7. DOI: 10.1016/0092-8674(92)90301-r. View

20.

Nathan C . Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992; 6(12):3051-64. View